Oncology and Hematology
1-16 of 568
- On the Frontlines of Metastatic Breast Cancer
Tracking Tumor Resistance in Metastatic Breast Cancer Care
Ryan Quigley
Megan Kruse, MD
Marlene Mimi Maeusli, PhD.
Brian P. McDonough, MD, FAAFP
Matthew Galsky, MD
Ryan Quigley
Kathrin M. Bernt, MD
Rushabh Mehta, BS
Fatemeh Alikarami
- MinuteCE®
Beyond the Joint: Cross-Specialty Solutions for Advancing TGCT Patient Care
1.00 credit 10 episodesA.J. Gelderblom, MD, PhD
Michiel van de Sande, MD, PhD
Chelsea Cole, MD
A.J. Gelderblom, MD, PhD
A.J. Gelderblom, MD, PhD
A.J. Gelderblom, MD, PhD
- MinuteCE®
Surgical Crossroads: Practical Considerations for Optimizing Treatment in TGCT
1.00 program creditA.J. Gelderblom, MD, PhD
Michiel van de Sande, MD, PhD
- MinuteCE®
Emerging Evidence in Focus: Interpreting Data on Next-Generation CSF1R TKIs
1.00 program creditA.J. Gelderblom, MD, PhD
- MinuteCE®
Applying the Evidence: TGCT Treatment Insights for Sports Medicine Physicians
1.00 program creditA.J. Gelderblom, MD, PhD
Chelsea Cole, MD
A.J. Gelderblom, MD, PhD
- MinuteCE®
Patient Perspective: Navigating TGCT Treatment—Surgery vs Systemic Therapy
1.00 program creditA.J. Gelderblom, MD, PhD
A.J. Gelderblom, MD, PhD
Michiel van de Sande, MD, PhD
Chelsea Cole, MD
Charles E. Geyer Jr., MD, FACP
- Oncology and Hematology
Additional Safey Data From TROPION-Breast02 and Study Design of TROPION-Breast06
Komal Jhaveri, MD, FACP
- Prev
- Next